About this journal

Drug Delivery publishes open access comprehensive peer-reviewed research articles on the development and application principles of drug delivery and targeting at molecular, cellular, and higher levels.

Drug Delivery aims to serve both the academic and industrial communities and accepts research on the following topics: 

• All aspects of drug delivery systems design and engineering for main routes of administration, including oral, pulmonary, nasal, parenteral, and transdermal delivery
• All aspects of formulations, such as controlled release systems and 3D printed dosage forms
• Nanomedicine and targeted drug delivery including lipid- and polymer-based nanoparticles, macromolecular conjugates, antibodies and nucleic acid delivery and gene editing systems
• Development of new materials with emphasis on biologics and biopharmaceutical delivery
• Biomimetic strategies for the design of drug delivery systems
• Personalized and recession drug delivery
• Theranostics
• Fundamental studies on interactions between drug delivery systems and nanomedicines with biological systems in vitro and in vivo
• Systems approaches to drug delivery and targeting
• Toxicology and safety of drug delivery systems
• Artificial intelligence, machine learning and mathematical and computational analysis in drug delivery and formulation engineering
• Controlled drug delivery in veterinary medicine
• Alternative methods to animal testing in drug delivery
• Industrial and regulatory issues

Papers on drug dosage forms and their optimization will not be considered unless they directly relate to the original drug delivery issues listed above. 

In addition to comprehensive and cutting-edge research articles, the journal welcomes for consideration the following paper types: Critical reviews, Systematic reviews, Brief reports (cutting-edge short papers describing significant advances in an area of drug delivery of broad interest), Case report, Discussion (perspective), Data note and Editorials. Perspectives and Editorials are by invitation only. 

Chief criteria for acceptance are novelty, originality, quality and clarity. All articles received by the Journal will be subject to a single-anonymous peer review.

Editor-in-Chief

Moein Moghimi, Professor of Nanomedicine and Pharmaceutics, School of Pharmacy, Newcastle University, UK, Professor, Translational and Clinical Research Institute, Newcastle University, UK, Adjoint Professor, University of Colorado Anschutz Medical Campus, CO, USA

Associate Editors

Ying Chau, Professor Department of Chemical and Biological Engineering, Director of Student Innovation for Global Health Technology, The Hong Kong University of Science and Technology, Hong Kong

Snjezana (Snow) Stolnik - Trenkic, Professor School of Pharmacy, University of Nottingham,PI and Director of EPSRC SFI Centre in Transformative Pharmaceutical Technologies, Director of EPSRC Centre for Advanced Therapeutics and Nanomedicines, UK

Advisory Editors

Patrick Couvreur, Emeritus Professor of Pharmacy, Paris-Saclay University, France

Robert Langer, David H. Koch Institute Professor, Massachusetts Institute of Technology, Cambridge, MA, USA

Glynn Wilson, Director Caring Brands Inc, USA, Board of Directors at Cadrenal Therapeutics, FL, USA

Editorial Board

Christine Allen, Professor in the Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada

Davide Brambilla, Associate Professor, Pharmacological faculty, University of Montreal, Canada

John Collett, Emeritus Professor University of Manchester, School of Health Sciences, Division of Pharmacy & Optometry, Manchester, England, UK

Ryan Donnelly, Professor, School of Pharmacy, Material and Advanced Technologies for Healthcare, Queen's University Belfast, Northern Ireland, UK

Gerard D'Souza, Professor of Pharmaceutics, Massachusetts College of Pharmacy, Boston, MA, USA

Elazer Edelman, Director, Institute for Medical Engineering & Science, Massachusetts Institute of Technology Edward J. Poitras Professor in Medical Engineering and Science Professor, Medicine, Brigham & Women's Hospital and Harvard Medical School, Cambridge/Boston, MA, USA

Omid Farokhzad, Associate Professor, Anesthesia, Harvard Medical School , Director, Laboratory of Nanomedicine and Biomaterials, Anaesthesia, Brigham And Women's Hospital, Harvard Medical School, Boston, MA, USA

Elias Fattal, Professor in Drug Delivery Science, University Paris-Saclay, Paris, France

Mitsuru Hashida, Professor Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan

Kenneth Howard, Associate Professor, Interdisciplinary Nanoscience Center - INANO-MBG, iNANO-huset, Aarhus University, Denmark

Shang-Hsiu Hu, Professor, Associate Vice President for R&D, Director, Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, Taiwan

Yoshita Ikada, Professor Kyoto University, Kyoto, Japan

Taichi Ito, Professor Chemical Bioengineering, Polymeric Biomaterials and Therapeutic Device, Department of Chemical Systems Engineering, Graduate School of Engineering, The University of Tokyo, Japan

Rakesh K Jain, A. Werk Cook Professor of Radiation Oncology (Tumor Biology), Harvard Medical School, Boston, MA, USA

Sangyong Jon, Chair Professor KAIST Korea Advanced Institute of Science and Technology, South Korea

Claus-Michael Lehr, Professorship for Biopharmacy and Pharmaceutical Technology, Saarland University, Saarbrücken, Germany

Abdel Omri, Professor in the Department of Chemistry and Biochemistry, Laurentian University, Greater Sudbury, ON, Canada

Jindrich Kopecek, Distinguished Professor of Molecular Pharmaceutics and Distinguished Professor of Biomedical Engineering, University of Utah, Salt Lake City, UT, USA

Vinod Labhasetwar, Professor Cleveland Clinic Lerner College of Medicine, Lerner Research Institute, Cleveland, Director, Cancer Nanomedicine Program, OH, USA

Karsten Mader, Professor, Head of the Institute of Pharmacy, Martin Luther University of Halle-Wittenberg, Halle, Germany

Ravin Narain, Professor Faculty of Engineering - Chemical and Materials Engineering Dept, University of Alberta, CA, USA

Ali Rajabi-Siahboomi, Vice President & Chief Innovation Officer, Colorcon, USA

Stefano Salmaso, Professor, Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Italy

Avi Schroeder, Professor Chemical Egineering, Israel Institute of Technology, Haifa, Israel

Anna Schwendeman, H.W. Vahlteich Professor and Professor of Pharmaceutical Sciences; and Faculty Associate in the Interdepartmental Program in Medicinal Chemistry, College of Pharmacy, University of Michigan, USA

Sevda Senel, Professor, Faculty of Pharmacy, Department of Pharmaceutical Technology, Pharmaceutical Technology, Hacettepe University, Turkey

Dmitri Simberg, Professor Colorado Center for Nanomedicine and Nanosafety, Co-Director Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, USA

Sonke Svenson, Cerulean Pharma Inc, Cambridge, MA, USA

Stavroula Sofou, Professor Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Whiting School of Engineering, Baltimore, MD, USA

María Jesus Vicent, Professor, Head of the Polymer Therapeutics Lab, CIBERONC, Spain

Ernst Wagner, Professor and Chair of Pharmaceutical Biology-Biotechnology, Center for System-based Drug Research, Department of Pharmacy, LM Universitat Munchen, München, Germany

Szu-Wen Wang, Professor Chemical and Biomolecular Engineering, Professor (Joint Appointment) Biomedical Engineering, USI Samueli School of Engineering, University of California, Irvine, USA

Wei Wu, Professor School of Pharmacy, Fudan University, China

Yi Yan Yang, Institute Scientist at the Bioprocessing Technology Institute and an Adjunct Professor (Research) at the Department of Orthopaedic Surgery, National University of Singapore, Singapore